Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oropharyngeal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00458978
What this trial is testing

Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more
National Cancer Institute (NCI) 6
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02281955
What this trial is testing

De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study

Who this might be right for
Carcinoma, Squamous CellHead and Neck NeoplasmsOropharyngeal Neoplasms
UNC Lineberger Comprehensive Cancer Center 115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06965738
What this trial is testing

Buccal Fat for Transoral Robotic Lateral Oropharyngectomy Defects to and Postoperative Pain

Who this might be right for
Tonsil NeoplasmOropharynx NeoplasmTransoral Robotic Surgery
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Looking for participantsNCT07807163
What this trial is testing

A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
Bicara Therapeutics 160
Testing effectiveness (Phase 2)Study completedNCT06007092
What this trial is testing

Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer

Who this might be right for
Head and Neck CarcinomaAdult Disease
Gustave Roussy, Cancer Campus, Grand Paris 24
Testing effectiveness (Phase 2)Looking for participantsNCT06636734
What this trial is testing

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown PrimaryMetastatic Head and Neck Squamous Cell Carcinoma+19 more
Emory University
Testing effectiveness (Phase 2)Study completedNCT00002964
What this trial is testing

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00665392
What this trial is testing

Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer

Who this might be right for
Head and Neck Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 42
Very early researchUnknownNCT00536952
What this trial is testing

Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy

Who this might be right for
Head and Neck Cancer
Northwestern University 36
Not applicableStudy completedNCT00898911
What this trial is testing

Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
ECOG-ACRIN Cancer Research Group 30
Early research (Phase 1)Ended earlyNCT04301011
What this trial is testing

Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors

Who this might be right for
Solid TumorMicrosatellite Stable Colorectal CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+6 more
Turnstone Biologics, Corp. 27
Not applicableStudy completedNCT00490282
What this trial is testing

A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOropharyngeal Cancer
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT04432597
What this trial is testing

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Who this might be right for
HPV Positive CancerVulvar, Vaginal, Penile, Rectal CancerAnal Cancer+2 more
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Looking for participantsNCT04151082
What this trial is testing

High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors

Who this might be right for
Cranial Nerve DisorderHead and Neck CarcinomaOropharyngeal Carcinoma
M.D. Anderson Cancer Center 35
Not applicableEnded earlyNCT02552550
What this trial is testing

Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
Centre Hospitalier Universitaire de Saint Etienne 12
Not applicableStudy completedNCT03729518
What this trial is testing

TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck

Who this might be right for
Oropharyngeal CancerSquamous Cell CarcinomaHuman Papilloma Virus
Abramson Cancer Center at Penn Medicine 150
Large-scale testing (Phase 3)UnknownNCT00002659
What this trial is testing

Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Matrix Pharmaceutical 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06167291
What this trial is testing

Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)

Who this might be right for
Oropharyngeal NeoplasmsRobotic Surgery and/or RadiotherapyLymphoscintigraphy
M.D. Anderson Cancer Center 8
Early research (Phase 1)Ended earlyNCT00033449
What this trial is testing

Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Stage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+5 more
National Cancer Institute (NCI) 30
Next Page
28